-The Economic Times Foreign pharma companies could be forced to overhaul their strategy for the Indian market by striking more local deals and cutting sky-high drug prices after the Supreme Court slammed the door on Swiss giant Novartis' attempts to gain a patent for its blood cancer-busting drug Glivec. But the ruling, welcomed by activists campaigning for affordable drugs and local generic companies, threatened to reinforce a narrative that India...
More »SEARCH RESULT
Novartis case may make foreign firms more wary of Indian drugs market-Ravi Ananthanarayanan
-Live Mint SC judgement may not open a floodgate of revenues for local pharma firms; nevertheless, it is a psychological win The Supreme Court has dismissed an appeal by Novartis AG to revoke denial of a patent to its cancer drug Glivec. The judgement is important because multinational companies (MNCs) can be denied patent protection on improved drugs unless they can prove the medication has better efficacy. Although this decision will displease...
More »Cash transfer of subsidy could save Rs 60,000 crore: Study -Surojit Gupta
-The Times of India Direct transfer of benefits in cash to targeted beneficiaries of food and fertilizer subsidies could save an estimated Rs 60,000 cr and help trim the fiscal deficit which, in turn, may calm stubbornly high food inflation, a study by a government wing has shown. The study showed that policies to rein in food inflation would require winding down of the fiscal deficit, which has gone above 8% of...
More »Patent war over drugs goes chronic -Rupali Mukherjee
-The Times of India MUMBAI: Turf war between Big Pharma and generic companies, which was largely restricted to exorbitantly priced life-saving drugs for cancer and HIV, is now spilling over to other chronic ailments like diabetes, and threatening to change dynamics of the nearly Rs 70,000 crore Indian pharma market. Triggering a full-blown patent fight with US-based Merck, domestic generic company Glenmark has launched a more affordable version of the multinational's blockbuster...
More »Madhya Pradesh topples Bihar, new No. 1 in economic Growth -Pradeep Thakur
-The Times of India BJP-led Madhya Pradesh dislodges champion Bihar from its numerouno position in terms of highest Growth of gross state domestic product. The provisional data released by the Central Statistical Organisation for 2012-13 for states shows Bihar's Growth has slowed, slipping from an impressive 13.26% last year to a single digit 9.48% this year as against 10% clocked by MP. Other backward states have maintained their upward trajectory, with Jharkhand...
More »